Literature DB >> 7379917

Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.

M J Zigmond, E M Stricker.   

Abstract

6-Hydroxydopamine increased behavioral response to L-DOPA in proportion to the decrease of dopamine (DA) and DA utake in rat striatum. The increase response to apomorphine, however, only occurred after greater than 80% DA loss. Thus, 6-hydroxydopamine may induce postsynaptic changes only following large lesions.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7379917     DOI： 10.1007/bf01975133

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  17 in total

1.  Cholinergic and dopaminergic blocking agents modulate water intake elicited by deprivation, hypovolemia, hypertomicity and isoproterenol.

Authors:  M L Block; A E Fisher
Journal:  Pharmacol Biochem Behav       Date:  1975 Mar-Apr       Impact factor: 3.533

2.  A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid.

Authors:  C F Saller; M J Zigmond
Journal:  Life Sci       Date:  1978-09-18       Impact factor: 5.037

3.  Neurochemical evidence for denervation supersensitivity: the effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels.

Authors:  H C Fibiger; D S Grewaal
Journal:  Life Sci       Date:  1974-07-01       Impact factor: 5.037

4.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Effect of lateral hypothalamic lesions on uptake of norepinephrine by brain homogenates.

Authors:  M J Zigmond; J P Chalmers; J R Simpson; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1971-10       Impact factor: 4.030

6.  Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats.

Authors:  M J Zigmond; E M Stricker
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

7.  Altered response to apomorphine in 6-hydroxydopamine-treated rats.

Authors:  R Schoenfeld; N Uretsky
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

8.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

9.  Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas.

Authors:  J T Coyle; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

10.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205
View more
  4 in total

1.  Distribution of dopamine, its metabolites, and D1 and D2 receptors in heterozygous and homozygous weaver mutant mice.

Authors:  T A Reader; A R Ase; C Hébert; F Amdiss
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.

Authors:  Judith P Golden; Joseph A Demaro; Amanda Knoten; Masato Hoshi; Elizabeth Pehek; Eugene M Johnson; Robert W Gereau; Sanjay Jain
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

3.  Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.

Authors:  E H Chartoff; B T Marck; A M Matsumoto; D M Dorsa; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Participation of brainstem monoaminergic nuclei in behavioral depression.

Authors:  Yan Lin; Yasmeen Sarfraz; Ashley Jensen; Adrian J Dunn; Eric A Stone
Journal:  Pharmacol Biochem Behav       Date:  2011-08-26       Impact factor: 3.533
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.